We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00654238
Recruitment Status : Completed
First Posted : April 7, 2008
Last Update Posted : June 23, 2014
Sponsor:
Information provided by (Responsible Party):
Marcia Brose, University of Pennsylvania

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2010
  Study Completion Date : March 2011